Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Australia may soon subsidize weight loss drugs like Ozempic and Wegovy, expanding access beyond diabetes patients.
Australia may soon offer subsidized access to weight loss drugs like Ozempic and Wegovy through its Pharmaceutical Benefits Scheme, potentially lowering costs for users.
Health Minister Mark Butler confirmed the government is evaluating a bid by Novo Nordisk to include Wegovy, with expert advice expected early in 2026.
Currently, these GLP-1 drugs are only subsidized for type 2 diabetes, leaving around half a million Australians paying privately between $200 and $600 monthly.
Concerns have been raised by the Therapeutic Goods Administration about possible links to suicidal thoughts and reduced effectiveness of oral contraceptives with some GLP-1 drugs.
The government aims to balance broader access with safety and equity.
Australia podría subsidiar pronto medicamentos para bajar de peso como Ozempic y Wegovy, ampliando el acceso más allá de los pacientes con diabetes.